Despite promising Phase 3 results, safety concerns, namely liver injury, have impacted Agios stock and could affect Pyrukund's approval and market adoption. Read the full report here.

Crispr Therapeutics AG has revenue declines but holds strong financials. Promising Sickle Cell therapy & 2025 data readouts ...

Vertex has entered a reimbursement agreement with NHS England enabling eligible SCD patients to access Casgevy in the public ...

Right now, approximately 20 billion red blood cells are busy traveling through your blood vessels. They are delivering oxygen ...

The FDA approved betibeglogene autotemcel (beti-cel; Zynteglo) for adult and pediatric patients with transfusion-dependent ...

With the addition of Casgevy, Children’s Hospital Los Angeles now offers two gene therapies for sickle cell, the first being Lyfgenia.

Explore the health benefits of red bananas, a nutrient-rich superfruit that boosts immunity, aids digestion, and supports heart health. Discover their role in weight loss and mood enhancement.

An A1C test is used to diagnose and monitor diabetes by measuring the body's average blood sugar level over the past three months. A high hemoglobin A1C, or A1C, shows your body has difficulty ...

The Federal Communications Commission (FCC) greenlit some of their plans in late 2024, paving the way for the announcement of the beta program. T-Mobile started notifying customers who were approved ...

iOS 18.3 is expected to be widely released next week, and that means the first iOS 18.4 beta for iPhones should be just around the corner. Apple has previously implied that iOS 18.4 will be ...